Nabriva Therapeutics plc(NBRVF.US)

Last Updated 19:00:00 ET
longbridge loading

Keenova Reports First Quarter 2026 Financial Results | MNK Stock News

StockTitan·
US
SEOVF
-6.34%
US
ITRM
0.00%
US
NBRVF
0.00%
StockTitan·
US
SEOVF
-6.34%
US
ITRM
0.00%
US
NBRVF
0.00%

Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock News

StockTitan·
US
NBRVF
0.00%
US
ITRM
0.00%
US
SEOVF
-6.34%
StockTitan·
US
NBRVF
0.00%
US
ITRM
0.00%
US
SEOVF
-6.34%

Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock News

StockTitan·
US
ITRM
0.00%
US
NBRVF
0.00%
US
SEOVF
-6.34%
StockTitan·
US
ITRM
0.00%
US
NBRVF
0.00%
US
SEOVF
-6.34%

06:30 ETKeenova Announces Unaudited Fourth Quarter 2025 Financial Results

prnewswire·
US
LABU
+10.49%
US
BBH
+0.45%
US
NBRVF
0.00%
prnewswire·
US
LABU
+10.49%
US
BBH
+0.45%
US
NBRVF
0.00%

Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge | MNK Stock News

StockTitan·
US
RNVA
0.00%
US
SEOVF
-6.34%
StockTitan·
US
RNVA
0.00%
US
SEOVF
-6.34%

REG - AIM - AIM Notice - 26/02/2026

London Stock Exchange·
US
ITRM
0.00%
US
ALLR
-0.67%
US
IBB
+1.74%
London Stock Exchange·
US
ITRM
0.00%
US
ALLR
-0.67%
US
IBB
+1.74%
© 2026 Longbridge｜Disclaimer